Edition:
United Kingdom

Lipocine Inc (LPCN.OQ)

LPCN.OQ on NASDAQ Stock Exchange Capital Market

1.37USD
17 Aug 2018
Change (% chg)

$-0.03 (-2.14%)
Prev Close
$1.40
Open
$1.39
Day's High
$1.40
Day's Low
$1.37
Volume
3,695
Avg. Vol
25,628
52-wk High
$4.36
52-wk Low
$1.03

Chart for

About

Lipocine Inc. is a specialty pharmaceutical company. The Company is focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men's and women's health. Its primary development programs are based on oral delivery solutions for bioavailable drugs. Its lead product... (more)

Overall

Beta: 1.04
Market Cap(Mil.): $81.66
Shares Outstanding(Mil.): 20.67
Dividend: --
Yield (%): --

Financials

  LPCN.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.91 -- --
ROI: -61.36 1.78 14.61
ROE: -61.36 3.28 16.33

BRIEF-Lipocine Receives Complete Response Letter For Tlando From U.S. FDA

* LIPOCINE RECEIVES COMPLETE RESPONSE LETTER FOR TLANDO FROM U.S. FOOD AND DRUG ADMINISTRATION

09 May 2018

BRIEF-Lipocine Announces Q1 Loss Per Share $0.13

* LIPOCINE ANNOUNCES FINANCIAL AND OPERATIONAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2018

07 May 2018

BRIEF-Lipocine Says ‍As Of December 31, 2017 Co Had Cash, Cash Equivalents And Marketable Securities Of $21.5 Mln​

* LIPOCINE ANNOUNCES FINANCIAL AND OPERATIONAL RESULTS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2017

12 Mar 2018

Earnings vs. Estimates